INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC. FILES APPLICATION FOR "2-(4-PIPERIDYL)-6-(IMIDAZO[1,2-B]PYRIDAZIN-6-YL)THIENO[3,2-B]PYRIDINE DERIVATIVES THAT REDUCE THE PROTEIN LEVEL OF HUNTINGTIN (HTT) FOR THE TREATMENT OF HUNTINGTON'S DISEASE"

GENEVA, May 4 -- F. HOFFMANN-LA ROCHE AG (Grenzacherstrasse 1244070 Basel), HOFFMANN-LA ROCHE INC. (Overlook at Great Notch, 150 Clove Road8th Floor, Suite 8 - Legal DepartmentLittle Falls, New Jersey 07424) filed a patent application (PCT/EP2025/080143) for "2-(4-PIPERIDYL)-6-(IMIDAZO[1,2-B]PYRIDAZIN-6-YL)THIENO[3,2-B]PYRIDINE DERIVATIVES THAT REDUCE THE PROTEIN LEVEL OF HUNTINGTIN (HTT) FOR THE TREATMENT OF HUNTINGTON'S DISEASE" on Oct 20, 2025. With publication no. WO/2026/087399, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inv...